MEDXF Projected Dividend Yield
Medexus Pharmaceuticals Inc ( OTCBB : MEDXF )Medexus Pharmaceuticals is engaged to provide healthcare products to healthcare professionals and patients. Co. focused on the therapeutic areas of auto-immune disease, hematology, and allergy. Co.'s products are: Rasuvo™ and Metoject®, unique formulations of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY®, an FDA-approved intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall®, a prescription allergy medication with a unique mode of action. 20 YEAR PERFORMANCE RESULTS |
MEDXF Dividend History Detail MEDXF Dividend News MEDXF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |